eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystoid macular dystrophy |
| Comorbidity | |retinal vein occlusion |
| Sentences | 118 |
| PubMedID- 24332373 | Study population: thirteen eyes of 13 treatment-naive patients undergoing serial intravitreal anti-vascular endothelial growth factor (vegf) injections for exudative age-related macular degeneration or macular edema attributable to retinal vein occlusion. |
| PubMedID- 25705695 | Objective: to compare the efficacy of different therapies in the treatment of macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 25885285 | Background: dexamethasone intravitreal implant (dex implant) is a sustained-release biodegradable implant approved for treatment of macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 24104718 | We report three patients of retinal vein occlusion with macular edema who demonstrated overnight resolution of macular edema following treatment with intravitreal ranibizumab (0.5 mg). |
| PubMedID- 19967679 | Purpose: aqueous levels of vascular endothelial growth factor (vegf) and interleukin-6 (il-6) are associated with the severity of macular edema in patients with central retinal vein occlusion (crvo). |
| PubMedID- 24894397 | Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema. |
| PubMedID- 20681253 | [pathogenesis of macular edema associated with branch retinal vein occlusion and strategy for treatment]. |
| PubMedID- 22080912 | Changes in visual acuity and foveal photoreceptor integrity in eyes with chronic cystoid macular edema associated with retinal vein occlusion. |
| PubMedID- 20714746 | Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. |
| PubMedID- 21652108 | [efficacy of early injection of intravitreal triamcinolone acetonide (ivta) versus delayed injection for macular edema resulting from retinal vein occlusion]. |
| PubMedID- 26305536 | Regional choroidal thickness changes in branch retinal vein occlusion with macular edema. |
| PubMedID- 25336905 | Direct photocoagulation to leakage points to treat chronic macular edema associated with branch retinal vein occlusion: a pilot study. |
| PubMedID- 22653545 | Purpose: to evaluate the changes of macular sensitivity, thickness, and total macular volume after intravitreal injection of triamcinolone acetonide to treat macular edema with branch retinal vein occlusion. |
| PubMedID- 26454243 | Purpose: to determine the ability of optical coherence tomography (oct) angiography to image the microvascular structures compared with fluorescein angiography (fa) in patients with macular edema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 26247458 | He developed a central retinal vein occlusion complicated by macular edema and received treatment with intravitreal bevacizumab, which led to resolution of the edema. |
| PubMedID- 23411880 | Objective: to evaluate the association between vitreous fluid levels of inflammatory factors and macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 23690676 | Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report. |
| PubMedID- 20827142 | Purpose: the purpose of this study was to evaluate the effect of intravitreal triamcinolone acetonide on macular function in cases of macular edema because of central retinal vein occlusion. |
| PubMedID- 24205253 | The geneva (global evaluation of implantable dexamethasone in retinal vein occlusion with macular edema) study evaluated the safety and efficacy of an intravitreal dexamethasone implant 0.7 mg versus an implant 0.35 mg versus sham injection in both brvo and crvo. |
| PubMedID- 20689798 | It is the occurrence of macular edema in retinal vein occlusion that most frequently leads to visual loss. |
| PubMedID- 19956967 | Macular microcirculation before and after vitrectomy for macular edema with branch retinal vein occlusion. |
| PubMedID- 23598674 | Twelve-month experience with ozurdex for the treatment of macular edema associated with retinal vein occlusion. |
| PubMedID- 22183139 | Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab. |
| PubMedID- 20429890 | These results suggest that the vitreous level of vascular endothelial growth factor might influence the visual prognosis and the response of macular edema to vitrectomy in patients with branch retinal vein occlusion. |
| PubMedID- 24068204 | The mechanisms responsible for macular edema with branch retinal vein occlusion (brvo) remain to be elucidated. |
| PubMedID- 25960733 | The patient developed acute severe abdominal pain and nausea the day after ivb for retinal vein occlusion with macular edema, and massive lower gastrointestinal bleeding occurred. |
| PubMedID- 20738886 | Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. |
| PubMedID- 21468337 | Scott et al23 demonstrated that the correlation between oct-measured center point thickness, and visual acuity letter score was statistically significant, but this relationship was, at best, modest in patients with macular edema associated with retinal vein occlusions. |
| PubMedID- 21275514 | Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. |
| PubMedID- 22823029 | Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (vegf), is widely used for the treatment of macular edema associated with central retinal vein occlusion (crvo). |
| PubMedID- 20935688 | Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment. |
| PubMedID- 21845030 | Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion. |
| PubMedID- 19430731 | We report a case of a 69-year-old male patient who came to our attention for macular edema in hemiretinal vein occlusion. |
| PubMedID- 26383643 | Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels. |
| PubMedID- 20103055 | Results: eyes with macular edema associated with retinal vein occlusion typically showed foveal cystoid spaces and marked retinal swelling, especially in the outer retina. |
| PubMedID- 23179231 | Intravitreal bevacizumab has been adopted as a well-established treatment modality for the treatment of macular edema associated with branch retinal vein occlusion. |
| PubMedID- 22553416 | The formation of lmh has been described in patients with diabetic cystoid edema and in chronic cystoid macular edema associated with retinal vein occlusion. |
| PubMedID- 24084497 | Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 galileo study. |
| PubMedID- 26418442 | Evaluation of multiple dexamethasone intravitreal implants in patients with macular edema associated with retinal vein occlusion. |
| PubMedID- 22481482 | Purpose: to investigate how combined cystoid spaces and serous retinal detachment affect photoreceptor status and visual acuity at final visit in macular edema associated with branch retinal vein occlusion. |
| PubMedID- 21734622 | Measurement of retinal sensitivity may be useful for assessing branch retinal vein occlusion patients with macular edema. |
| PubMedID- 22153634 | Recurrence of macular edema in retinal vein occlusions after treatment with intravitreal ranibizumab (lucentis). |
| PubMedID- 26428221 | Purpose: current treatment paradigms for macular edema associated with retinal vein occlusions (rvo) often involve initial treatment with anti-vascular endothelial growth factor (vegf) agents, then switching to intravitreal dexamethasone implant (idi; ozurdex, allergan, parsippany, nj) for poor responders. |
| PubMedID- 25371814 | Long-term outcome after vitrectomy for macular edema with retinal vein occlusion dividing into the occlusion site. |
| PubMedID- 25743778 | Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion. |
| PubMedID- 21911591 | Evaluation of macular function using focal macular electroretinography in eyes with macular edema associated with branch retinal vein occlusion. |
| PubMedID- 20182882 | Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. |
| PubMedID- 24847256 | We report a 19-year-old patient who developed a central retinal vein occlusion (crvo) with significant macular edema and visual impairment following intense exercise and dehydration. |
| PubMedID- 24884703 | Role of inflammation in previously untreated macular edema with branch retinal vein occlusion. |
| PubMedID- 25223207 | Subjects and methods: twenty seven eyes of 27 patients who had undergone vitrectomy for macular edema associated with branch retinal vein occlusion (brvo), proliferative diabetic retinopathy (pdr), macular hole (mh)/epiretinal membrane (erm) at toho university sakura medical center were studied. |